SAN DIEGO--(BUSINESS WIRE)--Sequenom, Inc. (NASDAQ:SQNM) today announced that the underwriters of its previously announced common stock offering that priced on June 25, 2008 have exercised in full an option to purchase an additional 825,000 shares of its common stock. Including the additional shares being purchased, the offering will total 6,325,000 shares at a public offering price of $15.50 per share, resulting in expected net proceeds to Sequenom of approximately $92.0 million (after deducting the underwriting discounts and commissions and other estimated offering expenses). Sequenom expects the net proceeds from the offering to be used for the development of diagnostic tests for use on its MassARRAY® system and other platforms, and for general corporate purposes. The closing for this sale of additional shares is scheduled to take place on or about July 8, 2008, subject to the satisfaction of customary closing conditions.
